Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,519,210
-
Share change
-
-6,454,572
-
Total reported value
-
$11,054,000
-
Price per share
-
$2.47
-
Number of holders
-
24
-
Value change
-
-$12,831,071
-
Number of buys
-
15
-
Number of sells
-
18
Institutional Holders of ENTASIS THERAPEUTICS HLDGS I - COM (ETTX) as of Q4 2020
As of 31 Dec 2020,
ENTASIS THERAPEUTICS HLDGS I - COM (ETTX) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,519,210 shares.
The largest 10 holders included
Pivotal bioVenture Partners Investment Advisor LLC, TPG Group Holdings (SBS) Advisors, Inc., EVENTIDE ASSET MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, Virtu Financial LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Anson Funds Management LP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, and Janney Montgomery Scott LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.